[Form 4] Bristol-Myers Squibb Co. Insider Trading Activity

Rhea-AI Filing Summary

Iron Mountain Inc. (IRM) has filed a Form 144/A signaling the possible sale of 17,334 common shares—about 0.006 % of the company’s 295,043,896 shares outstanding. The shares, acquired on 03/01/2025 via restricted-stock vesting (compensation), are valued at roughly $1.73 million and are expected to be sold on or after 07/01/2025 through Fidelity Brokerage Services LLC on the NYSE. No other sales were reported in the past three months, and the filer attests to holding no undisclosed material information. Although Form 144 filings can indicate insider intent to sell, the transaction size is immaterial relative to Iron Mountain’s float and therefore unlikely to affect the stock’s supply-demand dynamics.

Insights

Securities Analyst

TL;DR Proposed insider sale of 17,334 IRM shares is negligible; minimal impact expected.

The filing covers only 17,334 shares (≈0.006 % of outstanding), worth $1.73 million. Such a small disposition usually does not create meaningful selling pressure or change the firm’s ownership profile. Because the stock was acquired through recent restricted-stock vesting, it looks like routine compensation-related diversification rather than a signal of deteriorating fundamentals. I consider the filing neutral for valuation and liquidity.

Corporate Governance Expert

TL;DR Routine compensation share sale; governance risk remains unchanged.

Rule 144 requires insiders to notify the market before selling restricted securities. The absence of other recent sales and the representation of no undisclosed adverse information support good disclosure practice. Without the seller’s identity, we cannot assess alignment, but the minimal size and adherence to procedure suggest ordinary governance behavior. Overall governance impact is neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Samuels Theodore R. II

(Last) (First) (Middle)

BRISTOL-MYERS SQUIBB COMPANY

ROUTE 206 AND PROVINCE LINE ROAD

(Street)

PRINCETON NJ 08543

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRISTOL MYERS SQUIBB CO [ BMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	06/30/2025		A		1,080.147		(1)	(1)	Common Stock, $0.10 par value	1,080.147	$0	59,477.227(2)	D

Explanation of Responses:

1. Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

2. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Remarks:

EXHIBIT LIST: EX-24 Exhibit 24 - Theodore R. Samuels, GRAPHIC Exhibit 24 - Theodore R. Samuels

	/s/ Sophie M. Bail, attorney-in-fact for Theodore R. Samuels	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Iron Mountain (IRM) shares are covered by this Form 144?

17,334 common shares are included in the notice.

What is the aggregate market value of the shares to be sold?

The filing lists an aggregate value of approximately $1.73 million.

When were the shares acquired and by what method?

They were acquired on 03/01/2025 through restricted-stock vesting as compensation.

On what date may the shares be sold according to the filing?

The approximate sale date stated is 07/01/2025.

What percentage of IRM’s shares outstanding does this sale represent?

The proposed sale is roughly 0.006 % of the 295,043,896 shares outstanding.

Which broker will execute the transaction?

The sale is slated to be handled by Fidelity Brokerage Services LLC.

Were any shares sold by this insider in the prior three months?

No. The filing reports “Nothing to Report” for the past three months.